Bristol-Myers Squibb (BMY) Earnings Date & Reports
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
BMY is expected to report earnings to rise 15.75% to $1.69 per share on October 30
Q3'25
Est.
$1.69
Q2'25
Beat
by $0.40
Q1'25
Beat
by $0.28
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.30
The last earnings report on July 31 showed earnings per share of $1.46, beating the estimate of $1.06. With 1.40M shares outstanding, the current market capitalization sits at 93.53B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMY showed earnings on July 31, 2025. You can read more about the earnings report here.